Skip to Main Content

Author Details

Stacey L Burgess
University of Virginia School of Medicine
2013
22
14
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37276450Secondary bile acids function through the vitamin D receptor in myeloid progenitors to promote myelopoiesis.Blood Adv2023
34400793The IL-33-ILC2 pathway protects from amebic colitis.Mucosal Immunol2022
34248966Optimizing a Multi-Component Intranasal <i>Entamoeba Histolytica</i> Vaccine Formulation Using a Design of Experiments Strategy.Front Immunol2021
33688686IL-13 is a driver of COVID-19 severity.medRxiv2021
34185704IL-13 is a driver of COVID-19 severity.JCI Insight2021
32723427Evaluation of K18-<i>hACE2</i> Mice as a Model of SARS-CoV-2 Infection.Am J Trop Med Hyg2020
31260452Intestinal parasitic infection alters bone marrow derived dendritic cell inflammatory cytokine production in response to bacterial endotoxin in a diet-dependent manner.PLoS Negl Trop Dis2019
28817707Microbiome-mediated neutrophil recruitment via CXCR2 and protection from amebic colitis.PLoS Pathog2017
28246365Role of Eosinophils and Tumor Necrosis Factor Alpha in Interleukin-25-Mediated Protection from Amebic Colitis.mBio2017
28444240Nonspecific Effects of Oral Polio Vaccine on Diarrheal Burden and Etiology Among Bangladeshi Infants.Clin Infect Dis2017
28584161Parasitic Protozoa and Interactions with the Host Intestinal Microbiota.Infect Immun2017
27089535Interleukin-25 Mediated Induction of Angiogenin-4 Is Interleukin-13 Dependent.PLoS One2016
26631486Inflammatory markers predict episodes of wheezing during the first year of life in Bangladesh.Respir Med2016
27456830Role of Serum Amyloid A, Granulocyte-Macrophage Colony-Stimulating Factor, and Bone Marrow Granulocyte-Monocyte Precursor Expansion in Segmented Filamentous Bacterium-Mediated Protection from Entamoeba histolytica.Infect Immun2016
27271747Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.Infect Immun2016
27525214The Intestinal Bacterial Microbiome and <i>E. histolytica</i> Infection.Curr Trop Med Rep2016
27573114The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.Nat Microbiol2016
26712950Role of the Gut Microbiota of Children in Diarrhea Due to the Protozoan Parasite Entamoeba histolytica.J Infect Dis2016
24890599Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori.Antimicrob Agents Chemother2014
25516614Leptin receptor mutation results in defective neutrophil recruitment to the colon during Entamoeba histolytica infection.mBio2014
25370489Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis.mBio2014
24049732Differential colonization with segmented filamentous bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice.Mol Metab2013
  • 1 - 22 of 22

Recommended Authors

Cornell University
Career Start Year 2013
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 2012
Number of shared co-authors 0
Karolinska Institute, Center for Molecular Medicine
Career Start Year 2012
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 2012
Number of shared co-authors 0
University of California Riverside
Career Start Year 2010
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 2010
Number of shared co-authors 0
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 2007
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 2006
Number of shared co-authors 2
Cornell University
Career Start Year 2005
Number of shared co-authors 0
University of California san francisco
Career Start Year 2004
Number of shared co-authors 0
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 0
Children's Hospital of Philadelphia
Career Start Year 2004
Number of shared co-authors 2
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2003
Number of shared co-authors 0
Bar-Ilan University
Career Start Year 2003
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 0
German Cancer Research Center
Career Start Year 2002
Number of shared co-authors 2
South Australian Health and Medical Research Institute
Career Start Year 2002
Number of shared co-authors 0
Imperial College London
Career Start Year 2000
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 2000
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases
Career Start Year 1999
Number of shared co-authors 0
Indiana University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
B.C. Children's Hospital
Career Start Year 1997
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases
Career Start Year 1994
Number of shared co-authors 0
University of Calgary, 0 Hospital Drive NW
Career Start Year 1992
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 1986
Number of shared co-authors 2
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 3

Collaborators

University of Virginia
Co-authored papers 19
University of Virginia School of Medicine
Co-authored papers 7
Children's Hospital of Richmond at Virginia Commonwealth University
Co-authored papers 4
University of Virginia School of Medicine
Co-authored papers 4
University of Virginia
Co-authored papers 3
University of Virginia
Co-authored papers 3
University of Virginia
Co-authored papers 3
University of Virginiagrid.412587.dgrid.27755.32 School of Medicine
Co-authored papers 2
University of Virginia Health System. Charlottesville
Co-authored papers 2
University of Virginia
Co-authored papers 2
University of Virginia
Co-authored papers 2
Charite-Universitatsmedizin Berlin
Co-authored papers 2
University of Virginia
Co-authored papers 2
Lydia Becker Institute for Immunology & Infection, University of Manchester
Co-authored papers 2
Institute for Physiology, Charite-University Medicine Berlin
Co-authored papers 2
Virginia Commonwealth University.
Co-authored papers 2
Lydia Becker Institute for Immunology & Infection, University of Manchester
Co-authored papers 2
Virginia Commonwealth University.
Co-authored papers 2
University of Virginia School of Medicine
Co-authored papers 2
University of Virginia
Co-authored papers 2
University of Washington
Co-authored papers 2
Integrated Translational Health Research Institute of Virginia (iTHRIV)
Co-authored papers 2
Co-authored papers 1
Lydia Becker Institute of Immunology and Inflammation, University of Manchester
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
University of North Carolina School of Medicine
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1